Obesity Drug Use and Public Awareness Study

JAMA Network

About The Study: This repeated cross-sectional study including 69.2 million obesity management drug dispensed prescriptions revealed an increase from 0.76 million in July 2017 to 1.5 million in February 2024, with an upward trend in monthly phentermine and glucagon-like peptide 1 receptor agonist prescriptions. There was a robust positive correlation between public online search activity for semaglutide and tirzepatide and their prescription trends. The joint surge in prescriptions and online searches and their close correlation highlight the real-time associations between public awareness and prescription trends.

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.